Investing Profile

Markus Warmuth

InvestorVC
Venture Partner at Versant Ventures
versantventures.com/team/mark...Cambridge, Massachusetts
Photo of Markus Warmuth, Venture Partner at Versant Ventures
Your Intro Paths to Markus Warmuth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Markus is a member of
Novartis Network
74 CONNECTIONS
Third Rock Ventures Network
50 CONNECTIONS
Ludwig-Maximilians Universität München / University of Munich Network
41 CONNECTIONS
Ludwig-Maximilians-Universität München Network
33 CONNECTIONS
Versant Ventures Network
27 CONNECTIONS

Find Markus Warmuth on

cb
Current Investing Position
Versant Ventures Venture Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
3
Current Fund Size
$102.2M

Markus Warmuth is on these Sector & Stage Rankings

Markus Warmuth's Investments On Record (1)

CompanyStageDateRound SizeTotal Raised
Monte Rosa Therapeutics
Series CMar 2021$95M
Series BSep 2020$96M
Series AMay 2020$33M
$220M
Co-investors: David Schenkein (GV (Google Ventures)), Issi Rozen (GV (Google Ventures)), Ali Behbahani (New Enterprise Associates (NEA)), Chandra Leo (HBM Partners AG), Alexander Mayweg (Versant Ventures), Andrew Schiff (Aisling Capital)

Markus Warmuth's Experience

MD Ludwig-Maximilians-Universität MünchenPresent
Director Kinase Platform GNFPresent
Executive Director and Head of Oncology Drug Dicovery NovartisPresent
Independent Board Member Relay TherapeuticsPresent
Entrepreneur In Residence Third Rock VenturesPresent
Independent Board Member IMV Inc.Present
Member Board Of Directors Ventus TherapeuticsPresent
Venture Partner Versant VenturesPresent
Chief Executive Officer Monte Rosa TherapeuticsPresent

Markus Warmuth's Education

Ludwig-Maximilians-Universität München MD Medicine
Ludwig-Maximilians Universität München / University of Munich MD Medicine

Investors who invest with Markus Warmuth

Sign in with Google →

Scouts & Angels Affiliated With Markus Warmuth

Sign in with Google →